DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Agnelli G, Gussoni G, Bianchini C. et al.
on behalf of the PROTECHT Investigators. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.
Lancet Oncol 2009;
10: 943-949.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.